2. Duration of Therapy
There is no basis for limiting therapy duration for HMG-CoA reductase inhibitors as control of cholesterol and other coronary heart disease risk factors is a life-long process1-16.
There is no basis for limiting therapy duration for HMG-CoA reductase inhibitors as control of cholesterol and other coronary heart disease risk factors is a life-long process1-16.